Western Wealth Management LLC Sells 562 Shares of MetLife, Inc. (NYSE:MET)

Western Wealth Management LLC reduced its stake in shares of MetLife, Inc. (NYSE:MET) by 12.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,091 shares of the financial services provider’s stock after selling 562 shares during the quarter. Western Wealth Management LLC’s holdings in MetLife were worth $271,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the stock. Pzena Investment Management LLC increased its stake in MetLife by 118.1% during the third quarter. Pzena Investment Management LLC now owns 10,108,992 shares of the financial services provider’s stock worth $635,957,000 after acquiring an additional 5,474,449 shares during the last quarter. Northern Trust Corp boosted its position in shares of MetLife by 3.9% during the third quarter. Northern Trust Corp now owns 7,440,583 shares of the financial services provider’s stock valued at $468,087,000 after buying an additional 276,364 shares during the period. Invesco Ltd. boosted its position in shares of MetLife by 0.3% during the third quarter. Invesco Ltd. now owns 5,829,965 shares of the financial services provider’s stock valued at $366,763,000 after buying an additional 17,375 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of MetLife by 0.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 3,774,122 shares of the financial services provider’s stock valued at $237,430,000 after buying an additional 22,031 shares during the period. Finally, Envestnet Asset Management Inc. boosted its position in shares of MetLife by 15.3% during the third quarter. Envestnet Asset Management Inc. now owns 3,724,805 shares of the financial services provider’s stock valued at $234,327,000 after buying an additional 495,027 shares during the period. 89.81% of the stock is owned by institutional investors.

MetLife Stock Up 1.2 %

MetLife stock opened at $71.96 on Tuesday. The business has a fifty day moving average of $71.19 and a two-hundred day moving average of $66.94. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.53. The firm has a market cap of $52.03 billion, a P/E ratio of 39.32, a P/E/G ratio of 0.53 and a beta of 1.04. MetLife, Inc. has a twelve month low of $48.95 and a twelve month high of $74.68.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.02). The company had revenue of $18.72 billion for the quarter, compared to analysts’ expectations of $18.07 billion. MetLife had a return on equity of 19.48% and a net margin of 2.36%. On average, analysts forecast that MetLife, Inc. will post 8.71 earnings per share for the current fiscal year.

Insider Transactions at MetLife

In other news, insider Ramy Tadros sold 4,026 shares of the company’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the transaction, the insider now directly owns 146,981 shares of the company’s stock, valued at $10,567,933.90. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, EVP Bill Pappas sold 27,000 shares of the company’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the transaction, the executive vice president now directly owns 57,768 shares of the company’s stock, valued at $4,174,893.36. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Ramy Tadros sold 4,026 shares of the company’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the transaction, the insider now directly owns 146,981 shares in the company, valued at $10,567,933.90. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. The Goldman Sachs Group upgraded MetLife from a “neutral” rating to a “buy” rating and boosted their target price for the company from $70.00 to $80.00 in a research report on Monday, January 8th. Keefe, Bruyette & Woods boosted their target price on MetLife from $82.00 to $87.00 and gave the company an “outperform” rating in a research report on Wednesday, April 10th. Morgan Stanley boosted their price target on MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a report on Monday, April 15th. Piper Sandler boosted their price target on MetLife from $74.00 to $85.00 and gave the company an “overweight” rating in a report on Friday, April 5th. Finally, UBS Group lowered their price target on MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a report on Monday, February 5th. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $79.23.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.